Search Result "4-morpholinopyrrolopyrimidines"


3D-QSAR and Docking Studies of 4-morpholinopyrrolopyrimidine Derivatives as Potent mTOR Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 8 Issue: 4 Year: 2011 Page: 339-354
Author(s): Shao-Teng Wang, Yong Ai, Chu Tang, Fa-Jun Song, Ping-Hua Sun

Diverse Models for the Prediction of Dual mTOR and PI3Kα Inhibitory Activities of Substituted 4-morpholinopyrrolopyrimidines

Journal: Letters in Drug Design & Discovery
Volume: 11 Issue: 4 Year: 2014 Page: 454-473
Author(s): Monika Gupta,A. K. Madan

Graphical Abstracts

Journal: Letters in Drug Design & Discovery
Volume: 11 Issue: 4 Year: 2014 Page: i-vii
Author(s):

Graphical Abstracts

Journal: Letters in Drug Design & Discovery
Volume: 8 Issue: 4 Year: 2011 Page: i-v
Author(s):

Role of Moving Average Analysis for Development of Multi-Target (Q)SAR Models

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 15 Issue: 8 Year: 2015 Page: 659-676
Author(s): N. Khatri, R. Dutt, A.K. Madan

Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2686-2714
Author(s): S. J. Shuttleworth, F. A. Silva, A. R.L. Cecil, C. D. Tomassi, T. J. Hill, F. I. Raynaud, P. A. Clarke, P. Workman

Dual Inhibitors of PI3K/mTOR or mTOR-Selective Inhibitors: Which Way Shall We Go?

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 3 Year: 2011 Page: 5528-5544
Author(s): D. A. Sabbah, M. G. Brattain, H. Zhong

Results 1 - 1 of 7

Apply Filters

Volume Years

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy